Literature DB >> 28730896

Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.

John R Richards1, Jeff M Lapoint2, Guillermo Burillo-Putze3.   

Abstract

INTRODUCTION: Cannabinoid hyperemesis syndrome is a clinical disorder that has become more prevalent with increasing use of cannabis and synthetic cannabinoids, and which is difficult to treat. Standard antiemetics commonly fail to alleviate the severe nausea and vomiting characteristic of the syndrome. Curiously, cannabinoid hyperemesis syndrome patients often report dramatic relief of symptoms with hot showers and baths, and topical capsaicin.
OBJECTIVES: In this review, we detail the pharmacokinetics and pharmacodynamics of capsaicin and explore possible mechanisms for its beneficial effect, including activation of transient receptor potential vanilloid 1 and neurohumoral regulation. Putative mechanisms responsible for the benefit of hot water hydrotherapy are also investigated.
METHODS: An extensive search of PubMed, OpenGrey, and Google Scholar from inception to April 2017 was performed to identify known and theoretical thermoregulatory mechanisms associated with the endocannabinoid system. The searches resulted in 2417 articles. These articles were screened for relevant mechanisms behind capsaicin and heat activation having potential antiemetic effects. References from the selected articles were also hand-searched. A total of 137 articles were considered relevant and included. Capsaicin: Topical capsaicin is primarily used for treatment of neuropathic pain, but it has also been used successfully in some 20 cases of cannabinoid hyperemesis syndrome. The pharmacokinetics and pharmacodynamics of capsaicin as a transient receptor potential vanilloid 1 agonist may explain this effect. Topical capsaicin has a longer half-life than oral administration, thus its potential duration of benefit is longer. Capsaicin and transient receptor potential vanilloid 1: Topical capsaicin binds and activates the transient receptor potential vanilloid 1 receptor, triggering influx of calcium and sodium, as well as release of inflammatory neuropeptides leading to transient burning, stinging, and itching. This elicits a novel type of desensitization analgesia. Transient receptor potential vanilloid 1 receptors also respond to noxious stimuli, such as heat (>43 °C), acids (pH <6), pain, change in osmolarity, and endovanilloids. The action of topical capsaicin may mimic the effect of heat-activation of transient receptor potential vanilloid 1. Endocannabinoid system and transient receptor potential vanilloid 1: Cannabinoid hyperemesis syndrome may result from a derangement in the endocannabinoid system secondary to chronic exogenous stimulation. The relief of cannabinoid hyperemesis syndrome symptoms from heat and use of transient receptor potential vanilloid 1 agonists suggests a complex interrelation between the endocannabinoid system and transient receptor potential vanilloid 1. Temperature regulation: Hot water hydrotherapy is a mainstay of self-treatment for cannabinoid hyperemesis syndrome patients. This may be explained by heat-induced transient receptor potential vanilloid 1 activation. "Sensocrine" antiemetic effects: Transient receptor potential vanilloid 1 activation by heat or capsaicin results in modulation of tachykinins, somatostatin, pituitary adenylate-cyclase activating polypeptide, and calcitonin gene-related peptide as well as histaminergic, cholinergic, and serotonergic transmission. These downstream effects represent further possible explanations for transient receptor potential vanilloid 1-associated antiemesis.
CONCLUSIONS: These complex interactions between the endocannabinoid systems and transient receptor potential vanilloid 1, in the setting of cannabinoid receptor desensitization, may yield important clues into the pathophysiology and treatment of cannabinoid hyperemesis syndrome. This knowledge can provide clinicians caring for these patients with additional treatment options that may reduce length of stay, avoid unnecessary imaging and laboratory testing, and decrease the use of potentially harmful medications such as opioids.

Entities:  

Keywords:  Cannabinoid hyperemesis; TRPV1; cannabis; capsaicin; heat; hot shower

Mesh:

Substances:

Year:  2017        PMID: 28730896     DOI: 10.1080/15563650.2017.1349910

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  12 in total

1.  Cannabis hyperemesis syndrome.

Authors:  Umesh Sharma
Journal:  BMJ Case Rep       Date:  2018-10-14

Review 2.  Cannabis in Gastroenterology: Watch Your Head! A Review of Use in Inflammatory Bowel Disease, Functional Gut Disorders, and Gut-Related Adverse Effects.

Authors:  Yasmin Nasser; Matthew Woo; Christopher N Andrews
Journal:  Curr Treat Options Gastroenterol       Date:  2020-11-21

3.  Topical Capsaicin for Treating Cannabinoid Hyperemesis Syndrome.

Authors:  Ansar Aziz; Tayyab Waheed; Olubunmi Oladunjoye; Adeolu Oladunjoye; Midhat Hanif; Fareena Latif
Journal:  Case Rep Gastrointest Med       Date:  2020-11-27

Review 4.  Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms.

Authors:  Marieka V DeVuono; Linda A Parker
Journal:  Cannabis Cannabinoid Res       Date:  2020-06-05

5.  A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options.

Authors:  Helen Senderovich; Preet Patel; Briam Jimenez Lopez; Sarah Waicus
Journal:  Med Princ Pract       Date:  2021-11-01       Impact factor: 1.927

Review 6.  Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility.

Authors:  Asim Kichloo; Michael Albosta; Michael Aljadah; Zain El-Amir; Ghazaleh Goldar; Muhammed Zatmar Khan; Dushyant Singh Dahiya; Srilakshmi Vallabhaneni; Farah Wani; Jagmeet Singh
Journal:  SAGE Open Med       Date:  2021-03-09

Review 7.  Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.

Authors:  Weixia Zhong; Omar Shahbaz; Garrett Teskey; Abrianna Beever; Nala Kachour; Vishwanath Venketaraman; Nissar A Darmani
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

8.  Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation.

Authors:  Ethan B Russo; Chris Spooner; Len May; Ryan Leslie; Venetia L Whiteley
Journal:  Cannabis Cannabinoid Res       Date:  2021-07-05

9.  Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin.

Authors:  Andrew M Moon; Sarah A Buckley; Nicholas M Mark
Journal:  ACG Case Rep J       Date:  2018-01-03

10.  [Cannabinoid hyperemesis syndrome during pregnancy: A case report].

Authors:  Emmanuel Abreu Jáuregui; Ángeles López Hernández; Carmen Lorena Mendoza Romero; María Del Pilar Armas Pérez
Journal:  Aten Primaria       Date:  2019-12-18       Impact factor: 1.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.